These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29708242)

  • 1. Co-delivery of timolol and hyaluronic acid from semi-circular ring-implanted contact lenses for the treatment of glaucoma: in vitro and in vivo evaluation.
    Desai AR; Maulvi FA; Pandya MM; Ranch KM; Vyas BA; Shah SA; Shah DO
    Biomater Sci; 2018 May; 6(6):1580-1591. PubMed ID: 29708242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contact lenses with dual drug delivery for the treatment of bacterial conjunctivitis.
    Maulvi FA; Singhania SS; Desai AR; Shukla MR; Tannk AS; Ranch KM; Vyas BA; Shah DO
    Int J Pharm; 2018 Sep; 548(1):139-150. PubMed ID: 29960036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery.
    Maulvi FA; Lakdawala DH; Shaikh AA; Desai AR; Choksi HH; Vaidya RJ; Ranch KM; Koli AR; Vyas BA; Shah DO
    J Control Release; 2016 Mar; 226():47-56. PubMed ID: 26860285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple drug delivery from the drug-implants-laden silicone contact lens: Addressing the issue of burst drug release.
    Desai AR; Maulvi FA; Desai DM; Shukla MR; Ranch KM; Vyas BA; Shah SA; Sandeman S; Shah DO
    Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110885. PubMed ID: 32409042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy.
    Hsu KH; Carbia BE; Plummer C; Chauhan A
    Eur J Pharm Biopharm; 2015 Aug; 94():312-21. PubMed ID: 26071799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and optimization of a novel implantation technology in contact lenses for the treatment of dry eye syndrome: In vitro and in vivo evaluation.
    Maulvi FA; Shaikh AA; Lakdawala DH; Desai AR; Pandya MM; Singhania SS; Vaidya RJ; Ranch KM; Vyas BA; Shah DO
    Acta Biomater; 2017 Apr; 53():211-221. PubMed ID: 28131945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma.
    Xu J; Ge Y; Bu R; Zhang A; Feng S; Wang J; Gou J; Yin T; He H; Zhang Y; Tang X
    J Control Release; 2019 Jul; 305():18-28. PubMed ID: 31103677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended drug delivery by contact lenses for glaucoma therapy.
    Peng CC; Burke MT; Carbia BE; Plummer C; Chauhan A
    J Control Release; 2012 Aug; 162(1):152-8. PubMed ID: 22721817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of Brinzolamide and Timolol from Micelles-laden Contact Lenses: In vitro and In Vivo Evaluation.
    Yang H; Zhang F; Fan Y; Zhang J; Fang T; Xing D; Zhen Y; Nie Z; Liu Y; Wang D; Li J
    Pharm Res; 2024 Mar; 41(3):531-546. PubMed ID: 38366235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone-hydrogel contact lenses.
    Jung HJ; Abou-Jaoude M; Carbia BE; Plummer C; Chauhan A
    J Control Release; 2013 Jan; 165(1):82-9. PubMed ID: 23123188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of gold nanoparticles on timolol uptake and its release kinetics from contact lenses: In vitro and in vivo evaluation.
    Maulvi FA; Patil RJ; Desai AR; Shukla MR; Vaidya RJ; Ranch KM; Vyas BA; Shah SA; Shah DO
    Acta Biomater; 2019 Mar; 86():350-362. PubMed ID: 30625414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug delivery by contact lens in spontaneously glaucomatous dogs.
    Peng CC; Ben-Shlomo A; Mackay EO; Plummer CE; Chauhan A
    Curr Eye Res; 2012 Mar; 37(3):204-11. PubMed ID: 22335807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan nanoparticles laden contact lenses for enzyme-triggered controlled delivery of timolol maleate: A promising strategy for managing glaucoma.
    Maulvi FA; Patel AR; Shetty KH; Desai DT; Shah DO; Willcox MDP
    Drug Deliv Transl Res; 2024 Nov; 14(11):3212-3224. PubMed ID: 38407770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of timolol release from silicone hydrogel model contact lens materials using hyaluronic acid.
    Guidi G; Korogiannaki M; Sheardown H
    Eye Contact Lens; 2014 Sep; 40(5):269-76. PubMed ID: 25162288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case.
    Battistini FD; Tártara LI; Boiero C; Guzmán ML; Luciani-Giaccobbe LC; Palma SD; Allemandi DA; Manzo RH; Olivera ME
    Eur J Pharm Sci; 2017 Jul; 105():188-194. PubMed ID: 28506871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained Delivery of Timolol Using Nanostructured Lipid Carriers-Laden Soft Contact Lenses.
    Tian C; Zeng L; Tang L; Yu J; Ren M
    AAPS PharmSciTech; 2021 Aug; 22(6):212. PubMed ID: 34378099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended release of hyaluronic acid from hydrogel contact lenses for dry eye syndrome.
    Maulvi FA; Soni TG; Shah DO
    J Biomater Sci Polym Ed; 2015; 26(15):1035-50. PubMed ID: 26176811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A medical device/drug delivery system for treatment of glaucoma.
    Schultz CL; Poling TR; Mint JO
    Clin Exp Optom; 2009 Jul; 92(4):343-8. PubMed ID: 19389129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temperature sensitive contact lenses for triggered ophthalmic drug delivery.
    Jung HJ; Chauhan A
    Biomaterials; 2012 Mar; 33(7):2289-300. PubMed ID: 22182750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of performance characteristics of timolol-loaded composite ocular films as potential delivery platforms for treatment of glaucoma.
    Tighsazzadeh M; Mitchell JC; Boateng JS
    Int J Pharm; 2019 Jul; 566():111-125. PubMed ID: 31129346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.